^
CHEK2 mutation
Tongue Carcinoma
ABT-888 + M6620
Sensitive: C4 – Case Studies
FGFR2 P253R
Tongue Carcinoma
cetuximab
Sensitive: C4 – Case Studies
FGFR2 P253R
Tongue Carcinoma
pazopanib
Sensitive: C4 – Case Studies
EGF expression
Tongue Carcinoma
cetuximab
Resistant: D – Preclinical